IOM (Institute of Medicine). 2000. Vaccines for the 21st Century. Washington, DC: National Academy Press.

Klein, J.O., and M.G. Myers. 2006. Strengthening the supply of routinely administered vaccines in the United States: Problems and proposed solutions. Clin Infect Dis 42(Suppl 3):S97-S103.

Neumann, P.J., A.B. Rosen, D. Greenberg, N.V. Olchanski, R. Pande, R.H. Chapman, P.W. Stone, S. Ondategui-Parra, J. Nadai, J.E. Siegel, and M.C. Weinstein. 2005. Can we better prioritize resources for cost-utility research? Med Decis Making 25(4):429-436.

NVAC (National Vaccine Advisory Committee). 2007. June 7-8, 2007, Meeting Minutes. Available: [accessed July 12, 2009].

NVAC. 2009a (July). Draft Recommendations on 2009 H1N1 Influenza Vaccine Safety Monitoring. Available: [accessed October 14, 2009].

NVAC. 2009b (June). Recommendations on the Centers for Disease Control and Prevention Immunization Safety Office Draft 5-Year Scientific Agenda. Available: [accessed September 9, 2009].

Poland, G.A., R.M. Jacobson, and I.G. Ovsyannikova. 2009. Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27(25-26):3240-3244.

Richards, K. 2008. News Release: Delauro Holds Hearing on FDA Budget for the Center on Biologics Evaluation and Research. Available: [accessed November 19, 2009].

Strikas, R. 2008 (March 3). The National Vaccine Plan Process—Update. Presentation to the IOM Committee on Review of Priorities for the National Vaccine Plan. Washington, DC: IOM.

Vellozzi, C. 2009. Monitoring the Safety of Influenza A (H1N1) 2009 Monovalent Vaccines (PowerPoint Presentation). Immunization Safety Office, Division of Healthcare Quality Promotion. Atlanta, GA: CDC.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement